| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_93e8f3f0e161df3d09d4b9a837a21e23
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_216cb51c4fc33597e8bd304b3982f849 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55566
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-552
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2750-10034 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-0241
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-105
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-20 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-02 |
| filingDate |
2014-12-02^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fd4f31f2dfc0570d394c218813d9b7d2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9abb4088320f7ef182623bd59d84d6c5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_adf886d35cd090ac7937a85bd7d7e8b5 |
| publicationDate |
2015-06-11^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2015082458-A1 |
| titleOfInvention |
Vaccine against porcine circo virus type 2 |
| abstract |
The present invention pertains to a vaccine comprising a non-replicating immunogen of porcine circo virus type 2 for use in prophylactically treating an animal that has circulating antibodies directed against porcine circo virus type 2, against an infection with pathogenic porcine circo virus type 2 by a single dose administration of the vaccine into the dermis of the animal. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2018531265-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017068126-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108883169-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3076996-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2019512518-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11654191-B2 |
| priorityDate |
2013-12-03^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |